Evidence map›Paper›PMID 28759104›Full record

ReviewClinical and experimental immunology2017

The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.

C Vitulano, V Tedeschi, F Paladini, R Sorrentino, M T Fiorillo

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Associations betweenBioMed research international · 2021
    Pooled it
  2. [Psoriatic arthritis as MHC-I-associated disease].Zeitschrift fur Rheumatologie · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Biology of HLA class I associated inflammatory diseases.Best practice & research. Clinical rheumatology · 2024
    Review
  9. Article
  10. Article
  11. The Role of Aminopeptidase ERAP1 in Human Pathology-A Review.Current issues in molecular biology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Juvenile spondyloartropathies.European journal of rheumatology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

C VitulanoDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, Rome, Italy.
V TedeschiDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, Rome, Italy.
F PaladiniDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, Rome, Italy.
R SorrentinoDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, Rome, Italy.
M T FiorilloDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-6859-5851
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human leukocyte antigen class I gene HLA-B27 is the strongest risk factor for ankylosing spondylitis (AS), a chronic inflammatory arthritic disorder. More recently, the Endoplasmic Reticulum Aminopeptidase (ERAP) 1 and 2 genes have been identified by genome wide association studies (GWAS) as additional susceptibility factors. In the ER, these aminopeptidases trim the peptides to a length suitable to fit into the groove of the major histocompatibility complex (MHC) class I molecules. It is noteworthy that an epistatic interaction between HLA-B27 and ERAP1, but not between HLA-B27 and ERAP2, has been highlighted. However, these observations suggest a paramount centrality for the HLA-B27 peptide repertoire that determines the natural B27 immunological function, i.e. the T cell antigen presentation and, as a by-product, elicits HLA-B27 aberrant behaviours: (i) the misfolding leading to ER stress responses and autophagy and (ii) the surface expression of homodimers acting as ligands for innate immune receptors. In this context, it has been observed that the HLA-B27 carriers, besides being prone to autoimmunity, display a far better surveillance to some viral infections. This review focuses on the ambivalent role of HLA-B27 in autoimmunity and viral protection correlating its functions to the quantitative and qualitative effects of ERAP1 and ERAP2 polymorphisms on their enzymatic activity.

Indexed as

AminopeptidasesHLA-B27 AntigenMinor Histocompatibility AntigensSpondylitis, AnkylosingVirus DiseasesAutophagyEndoplasmic Reticulum StressEpistasis, GeneticGenome-Wide Association StudyHumansAminopeptidasesERAP1 protein, humanERAP2 protein, humanHLA-B27 AntigenMinor Histocompatibility Antigensankylosing spondylitisautoimmunityendoplasmic reticulum aminopeptidasesHLA-B27

Identifiers

PMID28759104
PMCPMC5680067
OpenAlexW2739935200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.